# Velan Capital Investment Management LP: Form 13F holdings

An institutional investment manager in ALPHARETTA, GA. SEC CIK 1848809.

- Quarter ended: 2026-06-30
- Filed: 2026-08-14
- Reported value: $164.2m
- Positions: 51 (53 lines in the filing's table; lines for the same security and option type are added together here)
- Compared with: the 13F for the quarter ended 2026-03-31
- Filing: https://www.sec.gov/Archives/edgar/data/1848809/000184880926000003/

## Holdings

As filed, largest first. Reported value is what the manager stated at the quarter end (Jun 30, 2026), in US dollars; it is filing data, not a price. Weight is the share of the total reported value.

| Issuer | Class | Reported value | Weight | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | ---: | --- | --- |
| [PRAXIS PRECISION MEDICINES I (PRAX)](/companies/prax.md) | COM NEW | $29.7m | 18.1% | 88,781 |  | Reduced −12,000 |
| [MAPLIGHT THERAPEUTICS INC (MPLT)](/companies/mplt.md) | COM | $17.7m | 10.8% | 492,893 |  | Unchanged |
| [SUTRO BIOPHARMA INC (STRO)](/companies/stro.md) | COM SHS | $17.0m | 10.4% | 512,160 |  | Unchanged |
| [IMMIX BIOPHARMA INC (IMMX)](/companies/immx.md) | COM | $11.2m | 6.8% | 1,085,000 |  | Added +345,000 |
| [PROTARA THERAPEUTICS INC (TARA)](/companies/tara.md) | COM STK | $10.9m | 6.6% | 2,844,652 |  | Added +10,000 |
| [ABIVAX SA (ABVX)](/companies/abvx.md) | SPONSORED ADS | $8.7m | 5.3% | 65,630 |  | Reduced −11,370 |
| [TENAX THERAPEUTICS INC (TENX)](/companies/tenx.md) | COM NEW | $8.0m | 4.9% | 549,985 |  | Reduced −33,348 |
| [ANTERIS TECHNOLOGIES GLOBAL (AVR)](/companies/avr.md) | COM | $6.9m | 4.2% | 700,000 |  | Unchanged |
| [EDESA BIOTECH INC (EDSA)](/companies/edsa.md) | COM NEW | $6.7m | 4.1% | 827,500 |  | Unchanged |
| [EVOMMUNE INC (EVMN)](/companies/evmn.md) | COM SHS | $6.0m | 3.7% | 451,255 |  | Added +5,000 |
| [AVALO THERAPEUTICS INC (AVTX)](/companies/avtx.md) | COM NEW | $6.0m | 3.7% | 324,452 |  | Added +139,330 |
| [XENCOR INC (XNCR)](/companies/xncr.md) | COM | $4.1m | 2.5% | 255,000 |  | Added +5,000 |
| [REZOLUTE INC (RZLT)](/companies/rzlt.md) | COM NEW | $3.9m | 2.4% | 750,000 |  | Unchanged |
| [HERON THERAPEUTICS INC (HRTX)](/companies/hrtx.md) | COM | $3.7m | 2.3% | 8,753,290 |  | Unchanged |
| [VERRICA PHARMACEUTICALS INC (VRCA)](/companies/vrca.md) | COM SHS | $2.9m | 1.8% | 471,559 |  | Unchanged |
| [C4 THERAPEUTICS INC (CCCC)](/companies/cccc.md) | COM STK | $2.7m | 1.6% | 570,000 |  | New +570,000 |
| [EUPRAXIA PHARMACEUTICALS INC (EPRX)](/companies/eprx.md) | COM | $2.3m | 1.4% | 352,000 |  | Unchanged |
| [ADMA BIOLOGICS INC (ADMA)](/companies/adma.md) | COM | $2.1m | 1.3% | 250,000 |  | New +250,000 |
| [REIN THERAPEUTICS INC (RNTX)](/companies/rntx.md) | COM NEW | $1.8m | 1.1% | 1,700,000 |  | New +1,700,000 |
| [LYELL IMMUNOPHARMA INC (LYEL)](/companies/lyel.md) | COM NEW | $1.5m | 0.9% | 105,000 |  | Added +3,000 |
| NASUS PHARMA LTD | ORD SHS | $1.3m | 0.8% | 359,390 |  | Unchanged |
| [PROFOUND MED CORP (PROF)](/companies/prof.md) | COM NEW | $1.1m | 0.7% | 170,278 |  | Reduced −115,432 |
| [JASPER THERAPEUTICS INC (JSPR)](/companies/jspr.md) | COM NEW | $1.1m | 0.7% | 2,668,395 |  | Unchanged |
| [TENAX THERAPEUTICS INC (TENX)](/companies/tenx.md) | COM NEW | $999.6k | 0.6% | 68,700 | Call | New +68,700 |
| [PROTAGONIST THERAPEUTICS INC (PTGX)](/companies/ptgx.md) | COM | $453.5k | 0.3% | 3,700 |  | Unchanged |
| [CYTOMX THERAPEUTICS INC. (CTMX)](/companies/ctmx.md) | COM | $450.0k | 0.3% | 120,000 |  | Reduced −420,000 |
| [NEUMORA THERAPEUTICS INC. (NMRA)](/companies/nmra.md) | COM | $391.0k | 0.2% | 230,000 |  | Added +150,000 |
| [NURIX THERAPEUTICS INC (NRIX)](/companies/nrix.md) | COM | $388.2k | 0.2% | 16,000 |  | Unchanged |
| [OVID THERAPEUTICS INC (OVID)](/companies/ovid.md) | COM | $349.7k | 0.2% | 130,000 |  | Reduced −30,000 |
| [PRECISION BIOSCIENCES INC (DTIL)](/companies/dtil.md) | COM NEW | $314.4k | 0.2% | 40,000 |  | Unchanged |
| [MINERALYS THERAPEUTICS INC (MLYS)](/companies/mlys.md) | COM | $296.8k | 0.2% | 11,000 |  | Unchanged |
| [MACROGENICS INC (MGNX)](/companies/mgnx.md) | COM | $277.2k | 0.2% | 60,000 |  | Added +30,000 |
| [CORBUS PHARMACEUTICALS HLDGS (CRBP)](/companies/crbp.md) | COM NEW | $243.9k | 0.1% | 26,000 |  | Unchanged |
| [ARTIVA BIOTHERAPEUTICS INC (ARTV)](/companies/artv.md) | COM | $242.5k | 0.1% | 25,000 |  | Unchanged |
| [REPLIMUNE GROUP INC (REPL)](/companies/repl.md) | COM | $221.4k | 0.1% | 20,000 |  | Unchanged |
| [SYNDAX PHARMACEUTICALS INC (SNDX)](/companies/sndx.md) | COM | $218.6k | 0.1% | 10,000 |  | Unchanged |
| [IMMUNOME INC (IMNM)](/companies/imnm.md) | COM | $211.9k | 0.1% | 10,000 |  | Unchanged |
| [TECTONIC THERAPEUTIC INC (TECX)](/companies/tecx.md) | COM | $206.3k | 0.1% | 6,000 |  | New +6,000 |
| [ROCKET PHARMACEUTICALS INC (RCKT)](/companies/rckt.md) | COM | $205.2k | 0.1% | 60,000 |  | Reduced −234,643 |
| [KARYOPHARM THERAPEUTICS INC (KPTI)](/companies/kpti.md) | COM NEW | $195.4k | 0.1% | 20,000 |  | Added +5,000 |
| [AN2 THERAPEUTICS INC (ANTX)](/companies/antx.md) | COM | $193.6k | 0.1% | 40,000 |  | New +40,000 |
| [VIRIDIAN THERAPEUTICS INC (VRDN)](/companies/vrdn.md) | COM | $183.7k | 0.1% | 10,000 |  | Reduced −81,123 |
| [SCYNEXIS INC (SCYX)](/companies/scyx.md) | COM | $162.8k | <0.1% | 40,000 |  | New +40,000 |
| [QUOIN PHARMACEUTICALS LTD (QNRX)](/companies/qnrx.md) | SPONSORED ADS | $156.7k | <0.1% | 32,372 |  | Reduced −52,477 |
| [XILIO THERAPEUTICS INC (XLO)](/companies/xlo.md) | COM | $136.8k | <0.1% | 14,285 |  | Unchanged |
| [INSPIREMD INC (NSPR)](/companies/nspr.md) | COM | $103.7k | <0.1% | 148,138 |  | Reduced −1,951,514 |
| [KALARIS THERAPEUTICS INC (KLRS)](/companies/klrs.md) | COM | $101.8k | <0.1% | 25,000 |  | Added +7,000 |
| [LARIMAR THERAPEUTICS INC (LRMR)](/companies/lrmr.md) | COM | $100.7k | <0.1% | 33,000 |  | Unchanged |
| PROQR THRAPEUTICS N V | SHS EURO | $83.7k | <0.1% | 45,000 |  | Unchanged |
| [CONTEXT THERAPEUTICS INC (CNTX)](/companies/cntx.md) | COM | $33.1k | <0.1% | 59,700 |  | Reduced −40,300 |
| GOSSAMER BIO INC | COM | $11.5k | <0.1% | 70,000 |  | Unchanged |

## Sold out

Held at the end of the quarter before and not reported this quarter.

| Issuer | Class | Reported value | Weight | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | ---: | --- | --- |
| [ARROWHEAD PHARMACEUTICALS IN (ARWR)](/companies/arwr.md) | COM | $0 | 0.0% | 0 |  | Sold out −6,500 |
| [DESIGN THERAPEUTICS INC (DSGN)](/companies/dsgn.md) | COM | $0 | 0.0% | 0 |  | Sold out −20,000 |
| ESPERION THERAPEUTICS INC NE | COM | $0 | 0.0% | 0 |  | Sold out −1,720,000 |
| [KAZIA THERAPEUTICS LTD (KZIA)](/companies/kzia.md) | SPONSORED ADS | $0 | 0.0% | 0 |  | Sold out −135,315 |
| [PMV PHARMACEUTICALS INC (PMVP)](/companies/pmvp.md) | COM | $0 | 0.0% | 0 |  | Sold out −73,000 |

Source: SEC EDGAR, Form 13F-HR, accession 0001848809-26-000003. Last ingested by Listed: Oct 22, 2026, 05:26 ET. No prices; not investment advice.